Neither BPC-157 nor TB-500 has received FDA approval for human use, placing them in the category of research compounds without official safety data in humans
Cellular energy metabolism modeling involving vitamin-supported biochemical cycles
Call your health care provider immediately if you are experiencing any signs of an allergic reaction: skin rash, itching or hives, swelling of the face, lips, or tongue, blue tint to skin, chest tightness, pain, difficulty breathing, wheezing, dizziness, red, swollen painful area on the leg
Comorbidities : Other metabolic conditions, such as the presence of type 2 diabetes, osteoarthritis, obstructive sleep apnea, and heart disease, also influence the effect of medication
Glycine may help reduce injection site reactions and improve tolerability for some users